BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11146438)

  • 1. Analysis of estrogen-responsive finger protein expression in benign and malignant human breast.
    Thomson SD; Ali S; Pickles L; Taylor J; Pace PE; Lymboura M; Shousha S; Coombes RC
    Int J Cancer; 2001 Jan; 91(2):152-8. PubMed ID: 11146438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen-responsive finger protein as a new potential biomarker for breast cancer.
    Suzuki T; Urano T; Tsukui T; Horie-Inoue K; Moriya T; Ishida T; Muramatsu M; Ouchi Y; Sasano H; Inoue S
    Clin Cancer Res; 2005 Sep; 11(17):6148-54. PubMed ID: 16144914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome mapping of human (ZNF147) and mouse genes for estrogen-responsive finger protein (efp), a member of the RING finger family.
    Inoue S; Orimo A; Matsuda Y; Inazawa J; Emi M; Nakamura Y; Hori T; Muramatsu M
    Genomics; 1995 Jan; 25(2):581-3. PubMed ID: 7789997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular cloning, structure, and expression of mouse estrogen-responsive finger protein Efp. Co-localization with estrogen receptor mRNA in target organs.
    Orimo A; Inoue S; Ikeda K; Noji S; Muramatsu M
    J Biol Chem; 1995 Oct; 270(41):24406-13. PubMed ID: 7592654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efp as a primary estrogen-responsive gene in human breast cancer.
    Ikeda K; Orimo A; Higashi Y; Muramatsu M; Inoue S
    FEBS Lett; 2000 Apr; 472(1):9-13. PubMed ID: 10781795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of estrogen-responsive finger protein (Efp) is associated with advanced disease in human epithelial ovarian cancer.
    Sakuma M; Akahira J; Suzuki T; Inoue S; Ito K; Moriya T; Sasano H; Okamura K; Yaegashi N
    Gynecol Oncol; 2005 Dec; 99(3):664-70. PubMed ID: 16140366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic distribution of estrogen-responsive finger protein (Efp) in human tissues.
    Shimada N; Suzuki T; Inoue S; Kato K; Imatani A; Sekine H; Ohara S; Shimosegawa T; Sasano H
    Mol Cell Endocrinol; 2004 Apr; 218(1-2):147-53. PubMed ID: 15130519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular cloning of rat efp: expression and regulation in primary osteoblasts.
    Inoue S; Urano T; Ogawa S; Saito T; Orimo A; Hosoi T; Ouchi Y; Muramatsu M
    Biochem Biophys Res Commun; 1999 Aug; 261(2):412-8. PubMed ID: 10425199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen-responsive RING finger protein controls breast cancer growth.
    Horie K; Urano T; Ikeda K; Inoue S
    J Steroid Biochem Mol Biol; 2003 Jun; 85(2-5):101-4. PubMed ID: 12943693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoter analysis of mouse estrogen-responsive finger protein (efp) gene: mouse efp promoter contains an E-box that is also conserved in human.
    Ikeda K; Inoue S; Orimo A; Tsutsumi K; Muramatsu M
    Gene; 1998 Aug; 216(1):155-62. PubMed ID: 9714786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efp promotes in vitro and in vivo growth of endometrial cancer cells along with the activation of nuclear factor-κB signaling.
    Sato W; Ikeda K; Urano T; Abe Y; Nakasato N; Horie-Inoue K; Takeda S; Inoue S
    PLoS One; 2018; 13(12):e0208351. PubMed ID: 30586414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic binding-site cloning reveals an estrogen-responsive gene that encodes a RING finger protein.
    Inoue S; Orimo A; Hosoi T; Kondo S; Toyoshima H; Kondo T; Ikegami A; Ouchi Y; Orimo H; Muramatsu M
    Proc Natl Acad Sci U S A; 1993 Dec; 90(23):11117-21. PubMed ID: 8248217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efp targets 14-3-3 sigma for proteolysis and promotes breast tumour growth.
    Urano T; Saito T; Tsukui T; Fujita M; Hosoi T; Muramatsu M; Ouchi Y; Inoue S
    Nature; 2002 Jun; 417(6891):871-5. PubMed ID: 12075357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uterine preparation for implantation in the mouse is associated with coordinate expression of estrogen-responsive finger protein and estrogen receptor.
    Das N; Wang J; Dey SK
    Mol Reprod Dev; 1997 Apr; 46(4):499-506. PubMed ID: 9094097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined Use of Immunoreactivities of RIG-I with Efp/TRIM25 for Predicting Prognosis of Patients With Estrogen Receptor-positive Breast Cancer.
    Sato J; Azuma K; Kinowaki K; Ikeda K; Ogura T; Takazawa Y; Kawabata H; Kitagawa M; Inoue S
    Clin Breast Cancer; 2021 Oct; 21(5):399-407.e2. PubMed ID: 33386231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oestrogen causes degradation of KLF5 by inducing the E3 ubiquitin ligase EFP in ER-positive breast cancer cells.
    Zhao KW; Sikriwal D; Dong X; Guo P; Sun X; Dong JT
    Biochem J; 2011 Jul; 437(2):323-33. PubMed ID: 21542805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple regulatory elements and binding proteins of the 5'-flanking region of the human estrogen-responsive finger protein (efp) gene.
    Ikeda K; Inoue S; Orimo A; Sano M; Watanabe T; Tsutsumi K; Muramatsu M
    Biochem Biophys Res Commun; 1997 Jul; 236(3):765-71. PubMed ID: 9245730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Underdeveloped uterus and reduced estrogen responsiveness in mice with disruption of the estrogen-responsive finger protein gene, which is a direct target of estrogen receptor alpha.
    Orimo A; Inoue S; Minowa O; Tominaga N; Tomioka Y; Sato M; Kuno J; Hiroi H; Shimizu Y; Suzuki M; Noda T; Muramatsu M
    Proc Natl Acad Sci U S A; 1999 Oct; 96(21):12027-32. PubMed ID: 10518570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptomic analysis of hormone-sensitive patient-derived endometrial cancer spheroid culture defines Efp as a proliferation modulator.
    Yang C; Ikeda K; Horie-Inoue K; Sato W; Hasegawa K; Takeda S; Itakura A; Inoue S
    Biochem Biophys Res Commun; 2021 Apr; 548():204-210. PubMed ID: 33647797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen-responsive RING finger mRNA induction in gastrointestinal carcinoma cells following bile acid treatment.
    Jung B; Vogt T; Mathieu-Daudé F; Welsh J; McClelland M; Trenkle T; Weitzel C; Kullmann F
    Carcinogenesis; 1998 Nov; 19(11):1901-6. PubMed ID: 9855000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.